Dr Pierre Meulien

Dr Pierre Meulien has been appointed president and CEO of Genome Canada, replacing interim president and CEO Dale Patterson and filling a gap that was created by the abrupt departure of Dr Martin Godbout last year (R$, October 26/09). Meulien comes from Genome BC where he served as chief scientific officer for 3.5 years. He has extensive private sector research management experience, including Aventis Pasteur (director of research in Lyon, France and senior VP R&D in Toronto), and Strasbourg-based Transgene. He holds a PhD from the Univ of Edinburgh and completed post-doctoral work at Institut Pasteur in Paris. Patterson returns to his role as Genome Canada's VP external relations….